Gisela Paulsen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gisela Paulsen
Gisela Paulsen is recorded as COO at Insight Molecular Diagnostics Inc. (IMDX). Insight Molecular Diagnostics Inc. reported in an 8-K filed December 21, 2022 that Gisela Paulsen resigned as officer, effective December 16, 2022. Insight Molecular Diagnostics Inc. reported in an 8-K filed December 21, 2022 that Gisela Paulsen was terminated as President and Chief Operating Officer, effective December 16, 2022. Insight Molecular Diagnostics Inc. reported in an 8-K filed August 10, 2022 that Gisela Paulsen was appointed President and Chief Operating Officer, effective August 8, 2022. The proxy statement of Insight Molecular Diagnostics Inc. reports total compensation of $1,341,125 for Gisela Paulsen in fiscal 2022, including a base salary of $356,426.
“Employee acknowledges and agrees that, as of the Termination Date, Employee will automatically be deemed to have resigned as an officer and any and all other positions and/or titles with the Company and agrees to execute any and all documentation the Company requests to effectuate the foregoing.”
“On December 16, 2022, Oncocyte issued a press release announcing its C-suite has been restructured and the positions occupied by Gisela Paulsen, President and Chief Operating Officer, and Douglas Ross, Chief Scientific Officer, will be eliminated.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-08-08–present
-
2022-08-08–2022-12-16
-
Start not stated–2022-12-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Insight Molecular Diagnostics Inc.
Other people whose current roles at this company are on record from its filings.
- Joshua Riggs CEO, Board Member
- Ronald Andrews CEO
- Andrew Arno Chairman, Board Member
- Andrea James CFO
- James Liu CFO, Chief Accounting Officer
- Mitchell Levine CFO
- Gisela A. Paulsen COO
- Li Yu Chief Accounting Officer
- Andrew J. Last Board Member
- Jennifer Levin Carter, MD Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Insight Molecular Diagnostics Inc. (IMDX) | Former President and Chief Operating Officer | $356,426 | $1,341,125 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.